107 related articles for article (PubMed ID: 21838138)
21. The effects of copayments and generic substitution on the use and costs of prescription drugs.
Smith DG
Inquiry; 1993; 30(2):189-98. PubMed ID: 8314607
[TBL] [Abstract][Full Text] [Related]
22. Trends in manufacturer prices of brand name prescription drugs used by older Americans--first quarter 2004 update.
Gross DJ; Schondelmeyer SW; Raetzman SO
Issue Brief (Public Policy Inst (Am Assoc Retired Pers)); 2004 Jun; (IB69):1-12, 1-2. PubMed ID: 15368653
[TBL] [Abstract][Full Text] [Related]
23. [Evaluation of prescription practices and of the rational use of medicines in Niger].
Mallet HP; Njikam A; Scouflaire SM
Sante; 2001; 11(3):185-93. PubMed ID: 11641083
[TBL] [Abstract][Full Text] [Related]
24. [Functional characteristics of pharmacy services related to home care in a certain suburban area].
Onda M; Kono K; Watanabe T; Watanabe M; Dote T; Usuda K; Shirai Y; Mima C
Nihon Koshu Eisei Zasshi; 2001 Jul; 48(7):534-42. PubMed ID: 11524828
[TBL] [Abstract][Full Text] [Related]
25. Do too many cooks spoil the broth? Multiple physician involvement in medical management of elderly patients and potentially inappropriate drug combinations.
Tamblyn RM; McLeod PJ; Abrahamowicz M; Laprise R
CMAJ; 1996 Apr; 154(8):1177-84. PubMed ID: 8612253
[TBL] [Abstract][Full Text] [Related]
26. PDP or MA-PD? Medicare part D enrollment decisions in CMS Region 25.
Cline RR; Worley MM; Schondelmeyer SW; Schommer JC; Larson TA; Uden DL; Hadsall RS
Res Social Adm Pharm; 2010 Jun; 6(2):130-42. PubMed ID: 20511112
[TBL] [Abstract][Full Text] [Related]
27. Adverse pharmaceutical payment incentives and providers' behaviour: the emergence of GP-owned gateway pharmacies in Taiwan.
Lee YC; Huang KH; Huang YT
Health Policy Plan; 2007 Nov; 22(6):427-35. PubMed ID: 17901065
[TBL] [Abstract][Full Text] [Related]
28. Reference-based pricing of prescription drugs: exploring the equivalence of angiotensin-converting-enzyme inhibitors.
Bourgault C; Elstein E; Le Lorier J; Suissa S
CMAJ; 1999 Aug; 161(3):255-60. PubMed ID: 10463046
[TBL] [Abstract][Full Text] [Related]
29. Effects of a prior-authorization policy for celecoxib on medical service and prescription drug use in a managed care Medicaid population.
Hartung DM; Touchette DR; Ketchum KL; Haxby DG; Goldberg BW
Clin Ther; 2004 Sep; 26(9):1518-32. PubMed ID: 15531015
[TBL] [Abstract][Full Text] [Related]
30. [Analysis of supplying situation in pharmacies: II. Availability of medicaments and health appliances from the viewpoint of the patient].
Macesková B; Holubková V
Ceska Slov Farm; 2007 Apr; 56(2):95-7. PubMed ID: 17619307
[TBL] [Abstract][Full Text] [Related]
31. Restrictions on the reimbursement policy with regard to retail marketing of medicinal products in Poland.
Zimmermann A
Acta Pol Pharm; 2013; 70(2):339-43. PubMed ID: 23614291
[TBL] [Abstract][Full Text] [Related]
32. Analysis of the impact of removing mucolytics and expectorants from the list of reimbursable drugs on prescription rates: a time-series analysis for France 1998-2010.
Pichetti S; Sorasith C; Sermet C
Health Policy; 2011 Oct; 102(2-3):159-69. PubMed ID: 21802761
[TBL] [Abstract][Full Text] [Related]
33. [Pharmacy Medicines Not Subject to Medical Prescription in Portugal: An Underused Access Opportunity?].
Martins AP; Gonçalves E; Marcelo A; Vilão S; Aranda Silva J
Acta Med Port; 2016 Sep; 29(9):542-548. PubMed ID: 28060692
[TBL] [Abstract][Full Text] [Related]
34. Community pharmacy naloxone supply, before and after rescheduling as an over-the-counter drug: sales and prescriptions data, 2014-2018.
Tse WC; Sanfilippo P; Lam T; Dietze P; Nielsen S
Med J Aust; 2020 Apr; 212(7):314-320. PubMed ID: 32124984
[TBL] [Abstract][Full Text] [Related]
35. When topical hydrocortisone became an OTC drug in Sweden--a study of the users and their information sources.
Brånstad JO; Kamil I; Lilja J; Sjöblom M
Soc Sci Med; 1994 Jul; 39(2):207-12. PubMed ID: 8066499
[TBL] [Abstract][Full Text] [Related]
36. [Differences between prescription and dispensing of generic medicines in primary care. When the exception is the rule].
Díez JI; Benounna H; Mayol CV; García RM
Gac Sanit; 2007; 21(5):404-6. PubMed ID: 17916305
[TBL] [Abstract][Full Text] [Related]
37. The Danish National Prescription Registry.
Kildemoes HW; Sørensen HT; Hallas J
Scand J Public Health; 2011 Jul; 39(7 Suppl):38-41. PubMed ID: 21775349
[TBL] [Abstract][Full Text] [Related]
38. Trends in outpatient prescription drug use and related costs in the US: 1998-2003.
Wysowski DK; Governale LA; Swann J
Pharmacoeconomics; 2006; 24(3):233-6. PubMed ID: 16519545
[TBL] [Abstract][Full Text] [Related]
39. [On the question of special over-the-counter drugs].
Kolár J
Ceska Slov Farm; 2011 Dec; 60(6):269-75. PubMed ID: 22312849
[TBL] [Abstract][Full Text] [Related]
40. [Medicinal products for human use in veterinary prescription].
Kolář J; Vargová L; Ambrus T
Ceska Slov Farm; 2015 Sep; 64(4):149-53. PubMed ID: 26459130
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
